Reece Armstrong

United Kingdom

Editor at Drug Discovery World

Journalist, video game lover and occasional musician. Deputy editor for Drug Discovery World.

Featured in: Favicon

ddw-online.com Favicon

tastingtable.com Favicon

gamegrin.com Favicon

med-technews.com Favicon

epmmagazine.com Favicon

medicalplasticsnews.com Favicon

rapidnews.com Favicon

pharmaceuticalmanufacturer.media

Articles

This week in drug discovery (26-30 May)

1 week ago | ddw-online.com | Reece Armstrong

News round-up for 26-30 May by DDW Editor Reece Armstrong. News stories of note for this week include a major deal signed between Eli Lilly and Rznomics in the field of RNA-editing therapies, and a potential quality-of-life breakthrough for patients with Parkinson’s. Lilly and Rznomics agree $1.3 billion RNA-editing dealEli Lilly has entered into an agreement to develop and commercialise novel RNA-editing therapies using Rznomics’ proprietary trans-splicing ribozyme platform.
Insilico Medicine study validates ENPP1 as immune checkpoint for cancers - Drug Discovery World (DDW)

1 week ago | ddw-online.com | Reece Armstrong

Biotechnology company Insilico Medicine has unveiled a new study showcasing how the company’s advanced generative AI platform and integrated workflow helped to identify and validate ENPP1 as a critical immune checkpoint among multiple solid tumors, which helped to the development of a highly specific oral ENPP1 inhibitor, ISM5939.
SLAS Europe round-up - Drug Discovery World (DDW)

1 week ago | ddw-online.com | Reece Armstrong

DDW looks at the latest announcements that came out of SLAS Europe. Contract research organisation (CRO) Nanoworx announced its nanomedicine development and optimisation services at this year’s SLAS Europe. The CRO’s new service is designed for academic and industry partners and is tailored to nanoparticle design and prototyping, nanomedicine high-throughput library construction and screening, nanomedicine production at scale, and in vitro assay testing.
DDW Tech Talks with Bruker Cellular Analysis

3 weeks ago | ddw-online.com | Reece Armstrong

In this new series, DDW Tech Talks explores how companies are utilising their products, services and technologies to advance drug discovery efforts. In this episode, we speak to Vikram Devgan VP of Global Marketing and Product Management, Bruker Cellular Analysis.
DDW Tech Talks with Bruker Cellular Analysis

3 weeks ago | ddw-online.com | Reece Armstrong

DDW Tech Talks with Bruker Cellular Analysis 16 May 2025 In this DDW Tech Talks, Vikram Devgan, VP of Global Marketing and Product Management at Bruker Cellular Analysis introduces the company’s Beacon Discovery platform, which has been developed to enable researchers to analyse live single cells in real time.
How real-time analysis of single cells can advance drug discovery - Drug Discovery World (DDW)

1 month ago | ddw-online.com | Reece Armstrong

DDW Editor Reece Armstrong speaks to Vikram Devgan, PhD, VP of Global Marketing and Product Management, Bruker Cellular Analysis, about how real-time access to single cells can drive functional insights. RA: How has single-cell research evolved over the past two decades?
The aggregation challenge: Measuring stability in therapeutic antibodies

2 months ago | ddw-online.com | Reece Armstrong

Salma Jalal, Market Development Manager at Refeyn looks at the need for and challenges of measuring antibody aggregation and discusses the ideal requirements of analytical tools to support it. Antibody therapies have cemented their place in modern healthcare, offering powerful, targeted treatments for cancers, autoimmune disorders, infectious diseases and beyond.
Register now for DDW's AI & ML summit

2 months ago | ddw-online.com | Reece Armstrong

Hosted by Drug Discovery World and sponsored by The Jackson Laboratory, register now for the DDW ‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery, to learn about the areas of opportunity for AI & ML in the drug discovery sector. Taking place on 30 April, 7am PDT / 10am EDT / 3pm BST / 4pm CEST, this free event will see experts and thought leaders in AI describe the latest research and applications that are driving the drug discovery process.
The future direction and applications of flow cytometry

2 months ago | ddw-online.com | Reece Armstrong

Miguel Tam, Director of Strategic Marketing at Revvity’s BioLegend, explores the future directions and applications of flow cytometry in drug discovery, highlighting the opportunities it presents and the challenges that lie aheadFlow cytometry has long been a cornerstone in biomedical research and clinical diagnostics, offering unparalleled capabilities to analyse multiple parameters of single cells in a high-throughput manner.
How has the biotech international market planning evolved

2 months ago | ddw-online.com | Reece Armstrong

Sam Tomlinson, Vice President of Global Drug Safety at Arriello unpacks North America/EU research which compares today’s commercialisation strategies with those of five years ago. As biotechs around the world look to new territories including emerging markets for their next returns, many are encountering unexpected hurdles. Too often, there is a significant gap between the envisaged opportunities and the practicalities and economics of accessing and converting them.